Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
Dupixent® significantly reduced COPD exacerbations in a successful Phase 3 trial, accelerating its FDA submission as a potential first approved biologic for this serious condition
Latest Hotspot
3 min read
Dupixent® significantly reduced COPD exacerbations in a successful Phase 3 trial, accelerating its FDA submission as a potential first approved biologic for this serious condition
1 December 2023
Dupixent® considerably cut down on COPD flare-ups in its subsequent effective Phase 3 investigation, hastening its FDA application and affirming its potential as the initial sanctioned biologic treatment for this severe illness.
Read →
Biological Glossary | What is Primer?
Bio Sequence
2 min read
Biological Glossary | What is Primer?
1 December 2023
In biology, a primer is a short single-stranded nucleic acid sequence that serves as a starting point for DNA synthesis.
Read →
Sosei Heptares to regain full rights to GSK4381406, a clinic-ready, novel oral GPR35 agonist for inflammatory bowel disease
Latest Hotspot
3 min read
Sosei Heptares to regain full rights to GSK4381406, a clinic-ready, novel oral GPR35 agonist for inflammatory bowel disease
1 December 2023
Sosei Heptares will reclaim complete ownership of GSK4381406*, a ready-for-clinic, unique oral GPR35 stimulant meant for inflamed bowel disorder.
Read →
Exploring Zilurgisertib's R&D successes and its clinical results at the 2023 ASH
Exploring Zilurgisertib's R&D successes and its clinical results at the 2023 ASH
1 December 2023
On Dec 11, 2023, new clinical data on zilurgisertib (INCB000928, LIMBER-104), alone or with ruxolitinib for myelofibrosis-related anemia, will be presented at ASH 2023.
Read →
Innovent announces China's NMPA priority review of first domestic KRAS G12C inhibitor drug, IBI351
Latest Hotspot
3 min read
Innovent announces China's NMPA priority review of first domestic KRAS G12C inhibitor drug, IBI351
1 December 2023
Innovent makes announcement: China's National Medical Products Administration has permitted and given precedence in reviewing the new drug application, IBI351 - the first KRAS G12C inhibitor from the country.
Read →
Biological Glossary | What is Precursor?
Bio Sequence
2 min read
Biological Glossary | What is Precursor?
1 December 2023
A precursor in biology refers to a substance, cell, or cellular component that serves as a predecessor or antecedent for another substance, cell, or cellular component.
Read →
Acrotech Biopharma and Evive Biotech have obtained FDA approval for Ryzneuta® to treat chemotherapy-induced Neutropenia (CIN)
Latest Hotspot
3 min read
Acrotech Biopharma and Evive Biotech have obtained FDA approval for Ryzneuta® to treat chemotherapy-induced Neutropenia (CIN)
1 December 2023
Acrotech Biopharma and Evive Biotech have successfully received FDA authorization to use Ryzneuta® (Efbemalenograstim alfa injection) for treating Neutropenia caused by Chemotherapy (CIN).
Read →
Deciphering JAK1 Inhibitors: Your Guide to Rapidly Accessing the Newest Advances
Deciphering JAK1 Inhibitors: Your Guide to Rapidly Accessing the Newest Advances
1 December 2023
JAK1 inhibitors: Transforming autoimmune and inflammatory disease treatments, with promising future developments.
Read →
EC Grants Marketing Approval for EirGenix's Biosimilar for Breast Cancer
Latest Hotspot
3 min read
EC Grants Marketing Approval for EirGenix's Biosimilar for Breast Cancer
1 December 2023
EirGenix Inc. has delivered news regarding the receipt of a marketing endorsement from the European Commission for their trastuzumab biosimilar medication (EG12014).
Read →
Screening Sequences In Bulk? FTO Clearance Is Just A Few Clicks Away
Bio Sequence
2 min read
Screening Sequences In Bulk? FTO Clearance Is Just A Few Clicks Away
1 December 2023
Batch sequence searches are even quicker with new batch search reports and ability to save all patent results to your workspace in one click. Learn how Bio lets you search hundreds of sequences for FTO clearance in a matter of minutes!
Read →
EU Commission Greenlights KAFTRIO® Paired with Ivacaftor to treat Cystic Fibrosis in Kids Aged 2-5
Latest Hotspot
3 min read
EU Commission Greenlights KAFTRIO® Paired with Ivacaftor to treat Cystic Fibrosis in Kids Aged 2-5
1 December 2023
Vertex Pharmaceuticals has announced that the European Commission has approved an expanded label for KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in combination with ivacaftor to treat cystic fibrosis in children aged 2 to 5 with at least one F508del mutation in the CFTR gene.
Read →
Unveiling the Secrets of IL-17A Inhibitors: Stay Updated with the Latest Advances
Unveiling the Secrets of IL-17A Inhibitors: Stay Updated with the Latest Advances
29 November 2023
IL-17A inhibitors are a class of drugs that target the cytokine IL-17A, playing a crucial role in treating inflammation and autoimmune diseases.
Read →